BioCardia Management
Management criteria checks 3/4
BioCardia's CEO is Peter Altman, appointed in Jan 2002, has a tenure of 22.17 years. total yearly compensation is $901.90K, comprised of 58.9% salary and 41.1% bonuses, including company stock and options. directly owns 2.14% of the company’s shares, worth $232.79K. The average tenure of the management team and the board of directors is 5.7 years and 7.4 years respectively.
Key information
Peter Altman
Chief executive officer
US$901.9k
Total compensation
CEO salary percentage | 58.9% |
CEO tenure | 22.2yrs |
CEO ownership | 2.1% |
Management average tenure | 5.7yrs |
Board average tenure | 7.4yrs |
Recent management updates
Recent updates
Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns
Oct 12BioCardia stock rises on contract for delivery products for BlueRock's cell therapies
Aug 24Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?
Aug 24Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation
May 10We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Jan 06We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Sep 23Why I've Taken A Small Position In BioCardia
Jun 14Shareholders May Not Be So Generous With BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation And Here's Why
Jun 08Is BioCardia (NASDAQ:BCDA) In A Good Position To Deliver On Growth Plans?
May 20BioCardia issued U.S. patent for Helix Biotherapeutic Delivery system
Dec 30BioCardia slips 11% on launch of direct offering
Dec 16BioCardia says DSMB feedback on cell therapy data in heart failure study anticipated soon
Dec 14What We Learned About BioCardia's (NASDAQ:BCDA) CEO Compensation
Dec 14CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$13m |
Jun 30 2023 | n/a | n/a | -US$13m |
Mar 31 2023 | n/a | n/a | -US$12m |
Dec 31 2022 | US$902k | US$531k | -US$12m |
Sep 30 2022 | n/a | n/a | -US$12m |
Jun 30 2022 | n/a | n/a | -US$12m |
Mar 31 2022 | n/a | n/a | -US$13m |
Dec 31 2021 | US$1m | US$488k | -US$13m |
Sep 30 2021 | n/a | n/a | -US$12m |
Jun 30 2021 | n/a | n/a | -US$13m |
Mar 31 2021 | n/a | n/a | -US$13m |
Dec 31 2020 | US$883k | US$380k | -US$15m |
Sep 30 2020 | n/a | n/a | -US$16m |
Jun 30 2020 | n/a | n/a | -US$15m |
Mar 31 2020 | n/a | n/a | -US$16m |
Dec 31 2019 | US$747k | US$363k | -US$15m |
Sep 30 2019 | n/a | n/a | -US$15m |
Jun 30 2019 | n/a | n/a | -US$15m |
Mar 31 2019 | n/a | n/a | -US$14m |
Dec 31 2018 | US$1m | US$360k | -US$14m |
Sep 30 2018 | n/a | n/a | -US$14m |
Jun 30 2018 | n/a | n/a | -US$13m |
Mar 31 2018 | n/a | n/a | -US$13m |
Dec 31 2017 | US$372k | US$310k | -US$12m |
Compensation vs Market: Peter's total compensation ($USD901.90K) is above average for companies of similar size in the US market ($USD662.11K).
Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.
CEO
Peter Altman (56 yo)
22.2yrs
Tenure
US$901,897
Compensation
Dr. Peter A. Altman, Ph.D. has been Chief Executive Officer and President of BioCardia, Inc. since 2002. Dr. Altman served as an acting Chief Executive Officer of Lumen Therapeutics from 2004 to 2005. He s...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 22.2yrs | US$901.90k | 2.14% $ 232.8k | |
Chief Financial Officer | 8yrs | US$565.10k | 0.52% $ 56.9k | |
Senior Vice President of Devices | 3.4yrs | US$389.70k | 0.19% $ 20.5k | |
Chief Medical Officer and VP of Clinical & Regulatory | 3.1yrs | no data | no data |
5.7yrs
Average Tenure
60yo
Average Age
Experienced Management: BCDA's management team is seasoned and experienced (5.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 22.2yrs | US$901.90k | 2.14% $ 232.8k | |
Independent Director | 13.2yrs | US$76.80k | 0.20% $ 21.3k | |
Independent Director | 7.4yrs | US$69.30k | 0.18% $ 19.8k | |
Independent Director | less than a year | no data | no data | |
Independent Director | 22.2yrs | US$60.80k | 5.75% $ 624.4k | |
Independent Director | 4.4yrs | US$60.80k | 3.45% $ 375.1k | |
Independent Chairman | 4.4yrs | US$109.30k | 1.94% $ 210.8k |
7.4yrs
Average Tenure
67yo
Average Age
Experienced Board: BCDA's board of directors are considered experienced (7.4 years average tenure).